You are here:
Nature Biotechnology

Nature Biotechnology

Get Alerts


View all

Sep 18, 2014

Pharmaceutical giant offers $2.2bn in stock and cash in effort to buy out men's health specialist

Pharmaceutical company Endo International has offered cash and stock valued at $2.2 billion to buy Auxilium Pharmaceuticals in a deal that would stop a tax-inversion deal Auxilium made for another drugmaker. Endo, which is incorporated in Ireland, bi... #Canada #Pennsylvania #QLT Inc. #Auxilium Pharmaceuticals, Inc. #Bloomberg #New York (state)